Covered recipient · General Payments record
JEFFERY W HOWARD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$9,168.51
- Reported across 657 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $431.92 | 29 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154.52 | 13 |
| Novo Nordisk AS | $146.42 | 9 |
| Lilly USA, LLC | $60.16 | 3 |
| Mylan Specialty L.P. | $20.88 | 1 |
| GlaxoSmithKline, LLC. | $18.73 | 1 |
| Inspire Medical Systems, Inc. | $17.06 | 1 |
| DEXCOM, INC. | $14.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2018201920202022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.90 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505963 | CMS |
| ABBVIE INC. | $17.03 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505965 | CMS |
| ABBVIE INC. | $19.92 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505967 | CMS |
| ABBVIE INC. | $13.64 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505969 | CMS |
| ABBVIE INC. | $15.02 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505971 | CMS |
| ABBVIE INC. | $10.55 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505973 | CMS |
| ABBVIE INC. | $11.07 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505975 | CMS |
| ABBVIE INC. | $13.66 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505977 | CMS |
| ABBVIE INC. | $11.42 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505979 | CMS |
| ABBVIE INC. | $2.35 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505981 | CMS |
| ABBVIE INC. | $13.23 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505983 | CMS |
| ABBVIE INC. | $11.53 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505985 | CMS |
| ABBVIE INC. | $11.20 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997505987 | CMS |
| Dexcom, Inc. | $14.15 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054881317 | CMS |
| GlaxoSmithKline, LLC. | $18.73 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001932839 | CMS |
| Inspire Medical Systems, Inc. | $17.06 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1058797695 | CMS |
| Lilly USA, LLC | $19.36 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031519253 | CMS |
| Lilly USA, LLC | $20.28 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031562649 | CMS |
| Lilly USA, LLC | $20.52 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031621723 | CMS |
| Mylan Specialty L.P. | $20.88 | 02/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1039070635 | CMS |
| Novo Nordisk Inc | $2.27 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698849 | CMS |
| Novo Nordisk Inc | $15.63 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698877 | CMS |
| Novo Nordisk Inc | $18.90 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698897 | CMS |
| Novo Nordisk Inc | $16.97 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698887 | CMS |
| Novo Nordisk Inc | $22.20 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698923 | CMS |
| Novo Nordisk Inc | $14.63 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698859 | CMS |
| Novo Nordisk Inc | $14.81 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698867 | CMS |
| Novo Nordisk Inc | $20.30 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698903 | CMS |
| Novo Nordisk Inc | $20.71 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000698913 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.